FindTrial
Sign In

Specialized spinal metastatic tumor cohort under the MDT diagnostic pathway

Specialized spinal metastatic tumor cohort under the MDT diagnostic pathway

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123704
Enrollment
Unknown
Registered
2026-04-29
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic tumor of the spine

Interventions

Exposure group:None
Control subjects:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients with spinal metastases; (2) presenting with MSCC symptoms; (3) complete case information; (4) patients during close regular follow-up

Exclusion criteria

Exclusion criteria: (1) revision surgery; (2) incomplete follow-up information; (3) those who died of other diseases; (4) those with poor baseline conditions and contraindications to surgery; (5) those who missed visits

Design outcomes

Primary

MeasureTime frame
Ssurvival;—

Secondary

MeasureTime frame
Tumor control;Safety indicators for therapeutic interventions;Clinical evaluation indicators;Quality of life assessment;Evaluation of the quality of diagnosis and treatment;—

Countries

China

Contacts

Public ContactWei Feng

Peking University Third Hospital

weifeng@bjmu.edu.cn+86 139 1123 0265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026